Audit 376210

FY End
2025-06-30
Total Expended
$8.20M
Findings
0
Programs
25
Year: 2025 Accepted: 2025-12-18
Auditor: KPMG LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.493 CONGRESSIONAL DIRECTIVES $3.00M Yes 0
93.103 FOOD AND DRUG ADMINISTRATION RESEARCH $1.35M Yes 0
11.029 TRIBAL BROADBAND CONNECTIVITY PROGRAM $227,280 Yes 0
93.211 TELEHEALTH PROGRAMS $217,944 Yes 0
93.213 RESEARCH AND TRAINING IN COMPLEMENTARY AND INTEGRATIVE HEALTH $183,374 Yes 0
93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING $123,931 Yes 0
93.136 INJURY PREVENTION AND CONTROL RESEARCH AND STATE AND COMMUNITY BASED PROGRAMS $110,243 Yes 0
93.155 RURAL HEALTH RESEARCH CENTERS $108,294 Yes 0
66.460 NONPOINT SOURCE IMPLEMENTATION GRANTS $90,773 Yes 0
93.110 MATERNAL AND CHILD HEALTH FEDERAL CONSOLIDATED PROGRAMS $79,439 Yes 0
93.399 CANCER CONTROL $77,362 Yes 0
93.837 CARDIOVASCULAR DISEASES RESEARCH $70,400 Yes 0
12.750 UNIFORMED SERVICES UNIVERSITY MEDICAL RESEARCH PROJECTS $68,596 Yes 0
10.932 REGIONAL CONSERVATION PARTNERSHIP PROGRAM $66,504 Yes 0
93.917 HIV CARE FORMULA GRANTS $63,159 Yes 0
93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH $58,191 Yes 0
93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS $47,655 Yes 0
93.898 CANCER PREVENTION AND CONTROL PROGRAMS FOR STATE, TERRITORIAL AND TRIBAL ORGANIZATIONS $34,688 Yes 0
93.RD NICHD CCTN OVAPRENE $32,489 Yes 0
93.361 NURSING RESEARCH $17,921 Yes 0
93.393 CANCER CAUSE AND PREVENTION RESEARCH $10,467 Yes 0
93.310 TRANS-NIH RESEARCH SUPPORT $10,373 Yes 0
97.036 DISASTER GRANTS - PUBLIC ASSISTANCE (PRESIDENTIALLY DECLARED DISASTERS) $7,149 Yes 0
93.307 MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH $1,469 Yes 0
93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH $-1,294 Yes 0

Contacts

Name Title Type
D529MMWMNHW3 Clinton Yee Auditee
8086911000 Danny Wong Auditor
No contacts on file

Notes to SEFA

The accompanying schedule of expenditures of federal awards includes the federal grant activity of The Queen’s Health Systems and its subsidiaries (the Company) and is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this schedule may differ from amounts presented in, or used in preparation of, the basic consolidated financial statements.
For the Research and Development Cluster, the Company did not elect to use the 10% de minimis indirect cost rate as discussed in the Uniform Guidance Section 200.414 as the Company has a negotiated rate with the United States Department of Health and Human Services for the year ended June 30, 2025. For programs other than the Research and Development cluster, the Company elected to use the 10% de minimus indirect cost rate as discussed in the Uniform Guidance Section 200.414 if indirect costs are applicable to the grant.
Nonfederal entities must record expenditures on the Schedule when FEMA has obligated the nonfederal entity’s project worksheet, and the nonfederal entity has incurred the eligible expenditures. The amount shown on the Schedule for the year ended June 30, 2025 includes $369,582 in expenditures that were incurred in prior years but were obligated in fiscal year 2025.